Re: Alemtuzumab induction in renal transplantation: A meta-analysis and systemic review. Zhang X, Huang H, Han S, Fu S, Wang L. Transpl Immunol. 2012 Oct;27(2-3):63-8 A recent systematic review and meta-analysis has been published in Transplant Immunology. The review by Zhang et al assesses the evidence for the use of Alemtuzumab as induction therapy in renal transplantation. […]
In this interesting analysis from the Collaborative Transplant Study the authors have analysed some 180,000 deceased donor kidney transplants performed between 1990 and 2009 and have found that the incidence of death with a functioning graft was 4.8% during the first year after transplant and 7.7% during years 2-5. The most frequent causes of death […]
The latest World Health Organization bulletin publishes an interview with Haibo Wang who is the Director of the China Organ Transplant Response System Research Centre for the Ministry of Health, a position he has held since 2011. He is interviewed by Fiona Fleck of the WHO and it is a very interesting interview, particularly with […]
Somehow or other I missed this very thoughtful editorial on the above subject which appeared in Lancet early in 2011, but better late than never! The editorial was stimulated by an announcement by the Minister of Health in the new Philippine government stating the ban on foreigners receiving transplants from Filipinos was to lifted and […]
In the latest CTS newsletter (November 1 2012) there is a very interesting analysis of the age of both donors and recipients over the last 25 years. This shows that the age of donors is steadily increasing with 31% of donors being greater than 60 years of age and 27% between 50 and 59 years […]
The December 2012 edition of the Transplant Trial Watch is now available on the CET website. Each month, the CET staff select 10 important recent RCTs in the field of transplantation and summarise and appraise their quality. This month, trials include alternative procedures for living donor nephrectomy, Rapamycin in simultaneous kidney pancreas transplants and Everolimus […]
This very interesting study is in publication in Transplantation. It is an analysis of deceased donor kidney graft survival in Europe and the USA based on CTS data and UNOS data comparing overall and age specific 1, 5 and 10 year graft survival for Europeans and white, African and Hispanic Americans over a 3 year […]
The November 2012 edition of the Transplant Trial Watch is now online. Each month the CET staff pick ten recent randomised controlled trials or systematic reviews to appraise the quality and comment on the findings. This month, trials include Rituximab as induction therapy in renal transplantation, Ephinenphrine for preventing postreperfision syndrome following liver transplantation and […]
You can now register for the EVIT course which will be held on 22nd and 23rd February 2013. The EVIT course, organised in collaboration with the European Society of Organ Transplantation, is a two-day course aimed at young professionals actively involved in organ and tissue transplantation who want to increase their skills in evidence-based decision-making. […]